Reaction

Thyroid Cancer Metastatic reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 281 reports · 2 co-occurring drugs

As of the last recalculation, Thyroid Cancer Metastatic appears in 281 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is SORAFENIB (PRR 93.5).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Sorafenib2493.593.6
Dabrafenib1036.436.4

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.